- Home
- PRT vs VNRX Comparison
PRT vs VNRX Comparison
Compare PRT & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRT | VNRX |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.3M | 24.5M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | PRT | VNRX |
|---|---|---|
| Price | $2.30 | $1.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $1.67 |
| AVG Volume (30 Days) | 75.0K | ★ 357.0K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | ★ 13.45% | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,727,384.00 |
| Revenue This Year | N/A | $355.66 |
| Revenue Next Year | N/A | $849.08 |
| P/E Ratio | $7.78 | ★ N/A |
| Revenue Growth | N/A | ★ 40.04 |
| 52 Week Low | $1.82 | $0.13 |
| 52 Week High | $4.28 | $3.26 |
Technical Indicators
Market Signals| Indicator | PRT | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 39.01 |
| Support Level | $1.82 | $1.30 |
| Resistance Level | $3.57 | $2.89 |
| Average True Range (ATR) | 0.15 | 0.18 |
| MACD | 0.05 | -0.11 |
| Stochastic Oscillator | 93.11 | 8.12 |
Price Performance
Historical ComparisonAbout PRT PermRock Royalty Trust Trust Units
PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on diagnostics and monitoring.